Skip to content

Zentalis Pharmaceuticals, Inc.

ZNTL· NasdaqCore metricsCIK 1725160

Pharmaceutical preparations551 peers

Close
Oct 23, 2026 · -3.70%
Market cap
$217.16M
98.26M shares
Filings
550
$0.00
FY 2025−100.0% FY25 yoy
-$28.82M
Q3 2026N/M FY25 yoy
-$31.15M
Q3 2026N/M FY25 yoy
-$102.93M
Q3 2026derivedN/M FY25 yoy
-$0.34
Q3 2026N/M FY25 yoy
$24.03M
Q3 2026+6.2% FY25 yoy
$217.16M
—
—
1.1×
-57.68%
—

FY2025 figures · derived

Price

$2.21+34.76%+$0.57past year
Oct 23, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$67.43M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$67,425,000reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$9.98M$9.98M—70.93M sh−1.2%—
FY2024—$0.00$0.00—71.81M sh+1.2%—
FY2023—$0.00$0.00—70.96M sh+19.4%—

Pharmaceutical preparations

Zentalis Pharmaceuticals, Inc. is the 246th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Zentalis Pharmaceuticals, Inc. · CIK 1725160 · Engraved from SEC EDGAR